Search Orphan Drug Designations and Approvals
-
Generic Name: | encorafenib + binimetinib | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Trade Name: | |||||||||||||||||
Date Designated: | 11/19/2013 | ||||||||||||||||
Orphan Designation: | Treatment of Stage IIB-IV melanoma positive for the BRAF mutation. | ||||||||||||||||
Orphan Designation Status: | Designated/Approved | ||||||||||||||||
Sponsor: |
Array BioPharma, Inc. 100 Cambridgepark Drive Suite 505 Cambridge, Massachusetts 02140 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
||||||||||||||||
Marketing approved: |
|||||||||||||||||
1 | Generic Name: | encorafenib + binimetinib |
---|---|---|
Trade Name: | ||
Marketing Approval Date: | 06/27/2018 | |
Approved Labeled Indication: | MEKTOVI® is indicated, in combination with encorafenib, for the treatment of patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation, as detected by an FDA-approved test | |
Exclusivity End Date: | 06/27/2025 | |
Exclusivity Protected Indication* : | BRAFTOVI¿ (encorafenib) and MEKTOVI® (binimetinib) indicated, in combination, for the treatment of patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation, as detected by an FDA-approved test. | |
2 | Generic Name: | encorafenib + binimetinib |
---|---|---|
Trade Name: | ||
Marketing Approval Date: | 06/27/2018 | |
Approved Labeled Indication: | BRAFTOVI¿ is indicated, in combination with binimetinib, for the treatment of patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation, as detected by an FDA-approved test | |
Exclusivity End Date: | 06/27/2025 | |
Exclusivity Protected Indication* : | BRAFTOVI¿ (encorafenib) and MEKTOVI® (binimetinib) indicated, in combination, for the treatment of patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation, as detected by an FDA-approved test. | |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-